Source: Eur Respir Monogr 2020; 88: 96-107



Rating:

Share or cite this content

Citations should be made in the following way:
Wei-jie Guan, Yong-hua Gao, David de la Rosa-Carrillo, Miguel Ángel Martínez-García. Cardiovascular implications in bronchiectasis. Eur Respir Monogr 2020; 88: 96-107

Member's Comments

No comment yet.

Related content which might interest you: Cardiovascular implications of pulmonary hypertension due to chronic respiratory diseases Source: Eur Respir Monogr 2020; 88: 167-183 Year: 2020 Clinical relevance of bronchiectasis in COPD Source: Annual Congress 2010 - COPD: diagnosis Year: 2010 Cardiovascular disease in COPD Source: Eur Respir Monogr 2020; 88: 47-65 Year: 2020 The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Clinical implications of small airways dysfunction in COPD Source: International Congress 2017 – From small airways dysfunction to dyspnoea in COPD: from physiology to clinical application Year: 2017 Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Determinants and assessment of excess cardiovascular risk in bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Relation of American Heart Association’s life’s simple 7 cardiovascular health factors with chronic obstructive pulmonary disease Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Management of bronchiectasis Source: Breathe 2010; 6: 353-360 Year: 2010 Cardiovascular complications of cystic fibrosis Source: Eur Respir Monogr 2020; 88: 108-117 Year: 2020 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study Source: Eur Respir J 2012; 39: 846-854 Year: 2012 Cardiovascular diseases and COVID-19 Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 The metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Clinical presentation and outcomes of venous thrombo-embolic diseases in chronic obstructive pulmonary diseases. Findings from the RIETE Registry Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010 Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes? Source: International Congress 2014 – The assessment of comorbidities Year: 2014